Close

Selecta Biosciences (SELB) Phase 1/2 Clinical Trial of SEL-302 for the Treatment of Methylmalonic Acidemia Placed on Clinical Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/16/2024

1. SPY
2. TSLA
3. RDDT
4. TCS:IN
5. ALAB
6. JPM
7. MSFT
8. AAPL
9. C
10. SCHW


Go back to Selecta Biosciences (SELB) Phase 1/2 Clinical Trial of SEL-302 for the Treatment of Methylmalonic Acidemia Placed on Clinical Hold

Selecta Biosciences (SELB) to Resume Trading at 4:45 p.m.

November 24, 2021 4:21 PM EST

Selecta Biosciences (NASDAQ: SELB) to Resume Trading at 4:45 p.m.

... More